Clinical Research on the Double Ways Combination Chemotherapy of Artery and Vein Treating the Liver Metastatic Tumours

廖子君,余国政,陈晓泉

DOI: https://doi.org/10.3971/j.issn.1000-8578.2004.05.018

2004-01-01

Abstract:Objective To observe the clinical effect and adverse reaction of the liver metastatic tumors treated by the combination chemotherapy of the two ways of artery and vein.Methods In according to the pathologic types of the primary tumors,the distinction of action and metabolism of chemicals,the cell cycle nonspecific agents(CCNSA) to be infused or add to embolism by the liver artery (except CTX and IFO),the cell cycle specific agents (CCSA) to be injected by peripheral vein,from each chemotherapy scheme. Vein injection was begun after the third day artery infusion,four weeks was a period,and it was be completed no less than three periods. To examine mainly liver CT and related tumor marks before the treatment each period,following period was from the end of treatment to death.Results Effectiveness and living were respectively lung squamous carcinoma 60.0% ? 13.2 months,lung adenocarcinoma 55.5% ? 10.8 months,SCLC 75.5% ? 31.4 months,carcinoma of stomach 53.3% ? 17.6 months,carcinoma of gallbladder 33.3% ? 10.9 months,carcinoma of large intestine 63.3% ? 18.8% months ,breast carcinoma 66.6% ? 21.7 months,oophoroma 66.6% ? 23.4 months. Related tumour marks had exceeded normal value before the treatment in 56 cases,however it had reduced obviously after the end of the third periods therapy,P 0.01 ,the same adverse reaction of the method as single vein chemotherapy.Conclusion The combination chemotherapy of artery and vein is a practical means among the treatment ways of liver metastatic tumors.